Sign In
Buy NVO
$47.64
+0.230 (+0.485%)
At Close: Jun 25, 2026
Novo Resources Corp. Unveils New Corporate Presentation for Investors
03:45pm, Wednesday, 09'th Apr 2025
PERTH, Western Australia, April 09, 2025 (GLOBE NEWSWIRE) -- Novo Resources Corp. (Novo or the Company) (ASX: NVO) (TSX: NVO) (OTCQB: NSRPF) is pleased to provide the launch of its April corporate pre
Explainer: Prescription drugs become a target in Trump's trade war
02:27pm, Wednesday, 09'th Apr 2025
U.S. President Donald Trump late on Tuesday reiterated he would impose tariffs on imports of pharmaceutical products that have long been spared from past trade disputes due to the potential for harm t
Healthy Returns: Trump says major pharmaceutical tariffs coming ‘very shortly'
01:06pm, Wednesday, 09'th Apr 2025
Trump doubled down on plans to soon impose "major" pharmaceutical tariffs, while early stage startups dominated digital health funding deals in first quarter.
5 Top Growth Stocks to Buy in the Stock Market Sell-Off
10:00am, Wednesday, 09'th Apr 2025
Equity markets may be struggling because of President Donald Trump's current economic policies, but that doesn't mean investors should avoid buying stocks right now -- quite the contrary. History tell
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
09:55am, Wednesday, 09'th Apr 2025
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
LLY vs. NVO: Which Weight-Loss Drug Stock is a Stronger Play Now?
11:10am, Tuesday, 08'th Apr 2025
Both LLY and NVO are leading pharmaceutical companies specializing in diabetes and obesity treatments.
Novo Nordisk A/S (NVO) Is a Trending Stock: Facts to Know Before Betting on It
10:06am, Tuesday, 08'th Apr 2025
Novo Nordisk (NVO) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Eli Lilly And Novo Nordisk Could Face Policy Shifts As FDA Oversight, Tariff Risks Mount
02:50pm, Monday, 07'th Apr 2025
Needham hosted Spencer Perlman, director of Healthcare Research at Veda Partners, an investment advisory and consulting firm with extensive expertise in government policy analysis. During the conversa
Novo Nordisk to invest $1.09 billion to increase production in Brazil
11:06am, Monday, 07'th Apr 2025
Novo Nordisk , the producer of Ozempic and other medications, announced on Monday a 6.4 billion reais ($1.09 billion) investment in Brazil to boost production.
NVO & LLY Shares Down on Exclusion of Obesity Drugs From Medicare
10:47am, Monday, 07'th Apr 2025
CMS keeps out LLY and NVO's obesity drugs from Medicare coverage. Medicare, at present, does not cover obesity drugs if they are solely prescribed for weight loss.
Eli Lilly, Novo Stocks Dive After Medicare Excludes Weight-Loss Drugs
05:55pm, Friday, 04'th Apr 2025
The Trump administration finalized new Medicare and Medicaid policies late Friday, but left out weight-loss drugs. Eli Lilly stock skidded.
1 Ideal Buy From 23 "Safer" April Dividend Dogs In 50 Fortune World's Most Admired Companies (FWMAC)
01:01pm, Friday, 04'th Apr 2025
1 Ideal Buy From 23 "Safer" April Dividend Dogs In 50 Fortune World's Most Admired Companies (FWMAC)
3 Rock-Solid Dividend Stocks That Will Grow Passive Income This Year
02:58pm, Thursday, 03'rd Apr 2025
Dividend stocks have been a reliable cornerstone for those who want to anchor their portfolios when markets get shaky.
Trump tariffs: these two European healthcare stocks face the highest US revenue exposure
09:34am, Thursday, 03'rd Apr 2025
Global financial markets are in turmoil this morning after the US President announced sweeping tariffs on several countries in a push to lower the nation's trade deficit. Trump's new tariffs are parti
Novo Nordisk's head of commercial strategy steps down
02:35am, Thursday, 03'rd Apr 2025
Novo Nordisk's head of commercial strategy and corporate affairs, Camilla Sylvest, has decided to leave the company, the Danish drugmaker said on Thursday.
